Clinical trial · Observational
Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists'Communication Styles
Seeking Informed Consent to Phase I Cancer Clinical Trials: Identifying Oncologists' Communication Styles
NCT00582192CI-TRIAL-00002276completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to examine doctor-patient communication about treatment options which may include an experimental, new treatment for cancer. What we learn from this study may help us to teach doctors better ways to talk to their patients.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer | Malignant Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Consult visit | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- 1
- description
- Participants with certain types of cancers that are eligible for studies at Memorial Sloan-Kettering Cancer Center.
- interventionNames
- Other: Consult visit
Primary outcomes (1)
- measure
- This study aims to use qualitative research methods to examine the pattern of communication strategies oncologists use to discuss Phase I clinical trials ith their patients.
- timeFrame
- This study will begin with your appointment with your doctor the day of registration and will end at the end of the visit that day.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients at the outpatient oncology clinics of the six participating physicians (Drs Schwartz, Scher, Slovin, Tse, Shah \& Carvajal) * Diagnosed with cancer * Eligible for a Phase I trial * Discussing participation in such a trial with their physician during their visit Exclusion Criteria: * Fewer than 18 years of age * Not proficient in English * Cognitively or physically impaired, rendering them incapable of providing informed consent to participate in the study
References
Publications (0)
Data not yet available
No reference posted for this study.